Mers-CoV 'On Course' According to the Published Genomic Replikin Count Predictions of 2012 and 2013
Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009
Completed in 4 days, First Batch of 20,000 doses of Freeze-Dried Solid Phase Synthetic Anti-Mers-CoV Vaccine Is Ready for Testing Today
LONDON, April 30, 2014 /PRNewswire/ -- Bioradar UK Ltd. and Replikins Ltd. announced today that the clinical course of the current Mers-CoV outbreak in southeast Asia is 'on course' according to the genomic Replikin Count predictions published on October 10, 2012 and on October 21, 2013.
Samuel Bogoch, MD, PhD
Read more news from Replikins.